The use of treatment table COMEX 30 for severe neurological decompression sickness | Canada Hyperbarics Skip to main content
Case Report Lakartidningen 2017

The use of treatment table COMEX 30 for severe neurological decompression sickness

Rosén A, Oscarsson N, Gräbel O, Sandström G — Lakartidningen, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on three cases where a specialized hyperbaric oxygen treatment, COMEX 30, was used to successfully treat severe neurological decompression sickness.

What They Found

The study found that in all three reported cases of severe neurological decompression sickness, treatment using the COMEX 30 recompression table successfully resolved the patients' neurological symptoms. This suggests that COMEX 30 can be an effective option when standard treatments like USN TT6 are insufficient for serious diving injuries.

Canadian Relevance

This study covers decompression sickness, which is a Health Canada-recognised indication for hyperbaric oxygen therapy. While the study itself was not conducted in Canada, its findings are relevant for Canadian divers and the hyperbaric medical community.

Study Limitations

As a case report, this study's findings are based on a very small number of patients and may not apply to all individuals with severe neurological decompression sickness.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 28221393
Year Published 2017
Journal Lakartidningen
MeSH Terms Adult; Decompression Sickness; Humans; Hyperbaric Oxygenation; Male; Risk Factors; Statistics as Topic

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology